Robert S, Forbes S, Soleimanian S, Hadley J
BMJ Case Rep. 2012; 2011.
PMID: 22674942
PMC: 3229323.
DOI: 10.1136/bcr.08.2011.4705.
Lozano-Lopez V, Rodriguez-Lozano B, Losada-Castillo M, Delgado-Frias E, Dopazo-Luque D, Serrano-Garcia M
J Ophthalmic Inflamm Infect. 2011; 1(2):71-5.
PMID: 21484179
PMC: 3102859.
DOI: 10.1007/s12348-010-0003-9.
Popa E, Stegeman C, Bos N, Kallenberg C, Cohen Tervaert J
Clin Exp Immunol. 2003; 132(3):496-504.
PMID: 12780698
PMC: 1808727.
DOI: 10.1046/j.1365-2249.2003.02157.x.
Wiik A
Arthritis Res Ther. 2003; 5(3):147-52.
PMID: 12723981
PMC: 165052.
DOI: 10.1186/ar758.
Al-Maini M, El-Ageb E, Al-Wahaibi S, Al-Farsi Y, Richens E
Rheumatol Int. 2003; 23(4):186-91.
PMID: 12679878
DOI: 10.1007/s00296-003-0303-6.
Proteinase-3 as the major autoantigen of c-ANCA is strongly expressed in lung tissue of patients with Wegener's granulomatosis.
Brockmann H, Schwarting A, Kriegsmann J, Petrow P, Gaumann A, Muller K
Arthritis Res. 2002; 4(3):220-5.
PMID: 12010574
PMC: 111026.
DOI: 10.1186/ar410.
Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung disease.
Mahadeva R, Dunn A, Westerbeek R, Sharples L, Whitehouse D, Carroll N
Clin Exp Immunol. 1999; 117(3):561-7.
PMID: 10469063
PMC: 1905355.
DOI: 10.1046/j.1365-2249.1999.01006.x.
Anti-proteinase-3 (PR3) antibodies (C-ANCA) recognize various targets on the human umbilical vein endothelial cell (HUVEC) membrane.
De Bandt M, Meyer O, Dacosta L, Elbim C, Pasquier C
Clin Exp Immunol. 1999; 115(2):362-8.
PMID: 9933466
PMC: 1905152.
DOI: 10.1046/j.1365-2249.1999.00799.x.
ANCA testing. New developments and clinical implications.
Ahmed A, Peter J, Shoenfeld Y
Clin Rev Allergy Immunol. 1998; 16(3):303-11.
PMID: 9773257
DOI: 10.1007/BF02737640.
Catalase and alpha-enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD).
Roozendaal C, Zhao M, Horst G, Lockwood C, Kleibeuker J, Limburg P
Clin Exp Immunol. 1998; 112(1):10-6.
PMID: 9566783
PMC: 1904946.
DOI: 10.1046/j.1365-2249.1998.00528.x.
Wegener's granulomatosis: anti-proteinase 3 antibodies are potent inductors of human endothelial cell signaling and leakage response.
Sibelius U, Hattar K, Schenkel A, Noll T, Csernok E, Gross W
J Exp Med. 1998; 187(4):497-503.
PMID: 9463400
PMC: 2212153.
DOI: 10.1084/jem.187.4.497.
Pulmonary vasculitis: classification, clinical features, and management.
Ciaccia A, Ferrari M, Facchini F, Caramori G, Fabbri L
Clin Rev Allergy Immunol. 1997; 15(1):73-95.
PMID: 9209803
DOI: 10.1007/BF02828279.
Anti-neutrophil cytoplasmic antibody in patients with systemic lupus erythematosus is unrelated to clinical features.
Nishiya K, Chikazawa H, Nishimura S, Hisakawa N, Hashimoto K
Clin Rheumatol. 1997; 16(1):70-5.
PMID: 9132329
DOI: 10.1007/BF02238766.
Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming.
Gilligan H, Bredy B, Brady H, Hebert M, Slayter H, Xu Y
J Exp Med. 1996; 184(6):2231-41.
PMID: 8976178
PMC: 2196384.
DOI: 10.1084/jem.184.6.2231.
Apoptosis of endothelial cells induced by the neutrophil serine proteases proteinase 3 and elastase.
Yang J, Kettritz R, Falk R, Jennette J, Gaido M
Am J Pathol. 1996; 149(5):1617-26.
PMID: 8909251
PMC: 1865283.